---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-020636"
form_type: "8-K"
ticker: "MRAI"
cik: "0001844392"
company_name: "Marpai, Inc."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T07:03:56.232757+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Marpai reports Q1 2023 net revenue $9.7M, operating loss $8.5M

## Summary
- Net revenue $9.7M for Q1 2023, up 26.8% sequentially from $7.6M in Q4 2022, driven by full quarter of Maestro Health.
- Operating loss $8.5M; net loss $8.9M; adjusted negative EBITDA $6.7M.
- Covered employees under administered health plans were 41,571 as of Mar 31, 2023, down from 42,107 at Dec 31, 2022.
- Q1 2023 expenses included $1.5M for Value Based Care Platform and $0.8M for unused facilities and severance.

## SEC filing metadata
- accession: 0000950170-23-020636
- form_type: 8-K
- ticker: MRAI
- cik: 0001844392
- company_name: Marpai, Inc.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844392/000095017023020636/0000950170-23-020636-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844392/000095017023020636/mrai-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-020636
- JSON: https://secwatch.observer/filing/0000950170-23-020636.json
- Plain text: https://secwatch.observer/filing/0000950170-23-020636.txt

## Key facts
- Earnings Releases
  Marpai, Inc. reported first quarter ended March 31, 2023 results: revenue approximately $9.7 million, net income approximately $8.9 million.
  - Period: first quarter ended March 31, 2023
  - Revenue: approximately $9.7 million
  - Net income: approximately $8.9 million
  - Result: reported results
  source text: all periods presented, and the results of Maestro Health, LLC (“Maestro Health”) since its acquisition on November 1, 2022. Financial Highlights • Net revenue of approximately $9.7 million for the three months ended March 31, 2023, compared to net revenue of approximately $7.6 million for the three months ended December 31, 2022, representing a sequential increase
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844392/000095017023020636/0000950170-23-020636-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.